Alliance Pharma acquires Biogix Inc. in a $110 million deal

LONDON: Alliance Pharma plc has completed the acquisition of 100% of the share capital of Biogix Inc, a privately held, US-based consumer healthcare company, for a total consideration of US$110.0 million paid for in cash from the Group’s existing financial resources, a news release said. Peter Butterfield, Chief Executive Officer of Alliance, commented: “As 2020…